[{"arm_notes": "", "treatment_id": null, "treatment_name": "Dosing and AdministrationSubjects will be randomized 1:1 to receive either active product or placebo. Initially; the trial will have 2 arms: -Remdesivir will be administered as a 200 mg IV loading dose on Day 1; followed by a 100 mg once-daily IV maintenance dose for the duration of the hospitalization up to a 10 day total course. If a subject is no longer hospitalized; then infusions will no longer be given. -A matching placebo will be given at an equal volume at the same schedule. Any dose that is delayed; but still the same study day; may be given. Any dose that is missed (not given that calendar day) is not made up.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Dosing and AdministrationSubjects will be randomized 1:1 to receive either active product or placebo. Initially; the trial will have 2 arms: -Remdesivir will be administered as a 200 mg IV loading dose on Day 1; followed by a 100 mg once-daily IV maintenance dose for the duration of the hospitalization up to a 10 day total course. If a subject is no longer hospitalized; then infusions will no longer be given. -A matching placebo will be given at an equal volume at the same schedule. Any dose that is delayed; but still the same study day; may be given. Any dose that is missed (not given that calendar day) is not made up.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]